تاريخ الإيرادات والأرباح والتدفقات النقدية من القوائم المالية الرسمية.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products, and professional food service products under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, Purell, GOJO, CloroxPro, Clorox Healthcare, Hidden Valley, Poett, Clorinda, and Chux brands.
الرسوم البيانية التفاعلية والقوائم الكاملة ← نموذج التقييم (DCF) ←
| قائمة الدخل | TTM → 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2011-06-30 | 2010-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 | 2006-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| إجمالي الإيرادات | $6.7B | $6.7B | $7.1B | $7.1B | $7.4B | $7.1B | $7.3B | $6.7B | $6.2B | $6.1B | $6.0B | $5.8B | $5.7B | $5.5B | $5.5B | $5.5B | $5.2B | $5.2B | $5.5B | $5.3B | $4.8B | $4.6B |
| إجمالي الربح | $2.8B | $2.8B | $3.2B | $3.0B | $2.9B | $2.5B | $3.2B | $3.1B | $2.7B | $2.7B | $2.7B | $2.6B | $2.5B | $2.4B | $2.4B | $2.3B | $2.3B | $2.3B | $2.3B | $2.2B | $2.1B | $2.0B |
| هامش الربح الإجمالي % | 42.3% | 42.3% | 45.2% | 43.0% | 39.4% | 35.8% | 43.6% | 45.6% | 43.9% | 43.7% | 44.7% | 45.1% | 43.6% | 42.7% | 43.2% | 42.1% | 43.5% | 44.3% | 43.0% | 41.2% | 43.1% | 42.2% |
| الدخل التشغيلي (EBIT) | $886M | $886M | $1.2B | $723M | $823M | $719M | $1.2B | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B | $1.0B | $969M | $964M | $903M | $921M | $973M | $1.0B | $888M | $867M | $779M |
| هامش التشغيل % | 13.2% | 13.2% | 16.6% | 10.2% | 11.1% | 10.1% | 16.7% | 18.8% | 17.8% | 18.4% | 18.7% | 18.3% | 17.7% | 17.6% | 17.4% | 16.5% | 17.6% | 18.6% | 18.7% | 16.8% | 17.9% | 16.8% |
| صافي الدخل | $587M | $587M | $810M | $280M | $149M | $462M | $710M | $939M | $820M | $823M | $701M | $648M | $580M | $558M | $572M | $541M | $557M | $603M | $537M | $461M | $501M | $444M |
| هامش الربح الصافي % | 8.7% | 8.7% | 11.4% | 4.0% | 2.0% | 6.5% | 9.7% | 14.0% | 13.2% | 13.4% | 11.7% | 11.2% | 10.3% | 10.1% | 10.3% | 9.9% | 10.7% | 11.5% | 9.8% | 8.7% | 10.3% | 9.6% |
| EBITDA | — | — | $1.4B | $723M | $564M | $937M | $1.2B | $1.5B | $1.3B | $1.3B | $1.3B | $1.2B | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B | $1.1B | $1.1B | $967M |
| ربحية السهم (EPS) | — | $4.81 | $6.52 | $2.24 | $1.20 | $3.73 | $5.58 | $7.35 | $6.32 | $6.25 | $5.33 | $4.92 | $4.37 | $4.24 | $4.30 | $4.08 | $4.03 | $4.26 | $3.81 | $3.25 | $3.25 | $2.90 |
| الأسهم القائمة (م) | — | — | 124M | 125M | 124M | 124M | 127M | 128M | 130M | 132M | 132M | 132M | 133M | 132M | 133M | 133M | 138M | 142M | 141M | 142M | 154M | 153M |
المصدر: التقارير العامة للشركة (SEC). تحقق من SEC EDGAR قبل الاعتماد على أي رقم.
الميزانيات والتدفقات النقدية والبيانات الفصلية والنسب المالية الكاملة في العارض التفاعلي لـ CLX. /companies/us/CLX
المعلومات في هذا الموقع لأغراض تعليمية وإعلامية فقط ولا تشكل نصيحة استثمارية. لا تُنشر أسعار مستهدفة أو توصيات.
About TickerBase · Data methodology & sources · Privacy · Terms